{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "24033605",
  "DateCompleted": {
    "Year": "2014",
    "Month": "03",
    "Day": "11"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "10",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2013",
        "Month": "10",
        "Day": "12"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1111/cas.12280"
    ],
    "Journal": {
      "ISSN": "1349-7006",
      "JournalIssue": {
        "Volume": "104",
        "Issue": "12",
        "PubDate": {
          "Year": "2013",
          "Month": "Dec"
        }
      },
      "Title": "Cancer science",
      "ISOAbbreviation": "Cancer Sci"
    },
    "ArticleTitle": "Tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma.",
    "Pagination": {
      "StartPage": "1567",
      "EndPage": "1574",
      "MedlinePgn": "1567-74"
    },
    "Abstract": {
      "AbstractText": [
        "Our recent studies of microRNA (miRNA) expression signatures have indicated that the miR-143/145 cluster is significantly downregulated in several types of cancer and represents a putative tumor-suppressive miRNA in human cancers. The aim of this study was to investigate the functional significance of the miR-143/145 cluster in cancer cells and to identify novel molecular targets of the miR-143/145 cluster in renal cell carcinoma (RCC). The expression levels of miR-143 and miR-145 were significantly downregulated in RCC tissues compared with adjacent non-cancerous tissues. A significant positive correlation was recognized between miR-143 and miR-145 expression. Restoration of mature miR-143 or miR-145 in 786-O and A498 RCC cells revealed that both mature miRNAs significantly inhibited cancer cell proliferation and invasion, suggesting that the miR-143/145 cluster functioned as a tumor suppressor in RCC. Gene expression data and in silico database analysis showed that the hexokinase-2 (HK2) gene, which encodes a glycolytic enzyme crucial for the Warburg effect in cancer cells, was a candidate target of the miR-143/145 cluster. Luciferase reporter assays showed that both miR-143 and miR-145 directly regulated HK2. In RCC clinical specimens, the expression of HK2 was significantly higher in cancer tissues than in non-cancerous tissues. Silencing HK2 suppressed RCC cell proliferation and invasion, suggesting that HK2 has oncogenic functions in RCC. Thus, our data showed that loss of the tumor-suppressive miR-143/145 cluster enhanced RCC cell proliferation and invasion through targeting HK2."
      ],
      "CopyrightInformation": "\u00a9 2013 Japanese Cancer Association."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan."
          }
        ],
        "LastName": "Yoshino",
        "ForeName": "Hirofumi",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Enokida",
        "ForeName": "Hideki",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Itesako",
        "ForeName": "Toshihiko",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kojima",
        "ForeName": "Satoko",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kinoshita",
        "ForeName": "Takashi",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Tatarano",
        "ForeName": "Shuichi",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Chiyomaru",
        "ForeName": "Takeshi",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Nakagawa",
        "ForeName": "Masayuki",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Seki",
        "ForeName": "Naohiko",
        "Initials": "N"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Cancer Sci",
    "NlmUniqueID": "101168776",
    "ISSNLinking": "1347-9032"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "MIRN143 microRNA, human"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "MIRN145 microRNA, human"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "MicroRNAs"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Small Interfering"
    },
    {
      "RegistryNumber": "EC 1.13.12.-",
      "NameOfSubstance": "Luciferases"
    },
    {
      "RegistryNumber": "EC 2.7.1.1",
      "NameOfSubstance": "Hexokinase"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Binding Sites"
    },
    {
      "QualifierName": [
        "genetics",
        "pathology"
      ],
      "DescriptorName": "Carcinoma, Renal Cell"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Line, Tumor"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Proliferation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Gene Expression"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genes, Tumor Suppressor"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Hexokinase"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "genetics",
        "pathology"
      ],
      "DescriptorName": "Kidney Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Luciferases"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "MicroRNAs"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Neoplasm Invasiveness"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Promoter Regions, Genetic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "RNA Interference"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "RNA, Small Interfering"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Up-Regulation"
    }
  ]
}